- Investing Ideas
- Swiss Pharmaceuticals & Biotech Most Popular Stocks
Swiss Pharmaceuticals & Biotech Most Popular Stocks
Results
23
Most Popular Stocks on the market
23 companies
Roche Holding
Market Cap: CHF 295.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 370.40
7D
2.5%
1Y
24.3%
Novartis
Market Cap: CHF 244.2b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 127.98
7D
1.2%
1Y
30.0%
Lonza Group
Market Cap: CHF 36.6b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 520.60
7D
-1.3%
1Y
-10.8%
Galderma Group
Market Cap: CHF 35.3b
Operates as a dermatology company worldwide.
GALD
CHF 148.60
7D
-1.5%
1Y
29.9%
Sandoz Group
Market Cap: CHF 28.6b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 66.36
7D
-0.3%
1Y
59.7%
Dottikon ES Holding
Market Cap: CHF 4.7b
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.
DESN
CHF 341.00
7D
1.6%
1Y
64.3%
Bachem Holding
Market Cap: CHF 4.2b
Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
BANB
CHF 56.15
7D
-11.6%
1Y
-4.1%
Siegfried Holding
Market Cap: CHF 3.5b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZN
CHF 79.00
7D
-11.6%
1Y
-21.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.9b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 116.20
7D
0.5%
1Y
70.4%
Tecan Group
Market Cap: CHF 1.7b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 133.40
7D
2.7%
1Y
-34.0%
SKAN Group
Market Cap: CHF 1.2b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 51.40
7D
0.6%
1Y
-33.3%
Kuros Biosciences
Market Cap: CHF 999.0m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 25.50
7D
2.0%
1Y
14.6%
Idorsia
Market Cap: CHF 919.3m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.66
7D
-6.4%
1Y
278.8%
PolyPeptide Group
Market Cap: CHF 816.5m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 24.75
7D
-5.2%
1Y
10.7%
Basilea Pharmaceutica
Market Cap: CHF 642.8m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 52.30
7D
-6.1%
1Y
13.8%
Newron Pharmaceuticals
Market Cap: CHF 372.3m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 18.60
7D
-5.6%
1Y
82.0%
Santhera Pharmaceuticals Holding
Market Cap: CHF 229.2m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANN
CHF 16.46
7D
-2.0%
1Y
2.4%
Molecular Partners
Market Cap: CHF 144.0m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.85
7D
6.5%
1Y
-10.9%
BioVersys
Market Cap: CHF 137.4m
A clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria.
BIOV
CHF 23.50
7D
1.3%
1Y
-34.1%
Xlife Sciences
Market Cap: CHF 131.5m
Focuses on the development and commercialization of research projects in the life sciences sector.
XLS
CHF 22.80
7D
7.5%
1Y
21.0%
MindMaze Therapeutics Holding
Market Cap: CHF 130.0m
Develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
MMTX
CHF 0.85
7D
-19.6%
1Y
n/a
Curatis Holding
Market Cap: CHF 89.9m
Engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
CURN
CHF 17.45
7D
-2.2%
1Y
64.6%
Addex Therapeutics
Market Cap: CHF 5.6m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland.
ADXN
CHF 0.048
7D
-3.2%
1Y
-31.4%